Literature DB >> 29321329

A Cyclin-Binding Motif in Human SAMHD1 Is Required for Its HIV-1 Restriction, dNTPase Activity, Tetramer Formation, and Efficient Phosphorylation.

Corine St Gelais1, Sun Hee Kim1, Victoria V Maksimova1,2, Olga Buzovetsky3, Kirsten M Knecht3, Caitlin Shepard4, Baek Kim4,5, Yong Xiong3, Li Wu6.   

Abstract

Sterile alpha motif and HD domain-containing protein 1 (SAMHD1) regulates intracellular deoxynucleoside triphosphate (dNTP) levels and functions as a retroviral restriction factor through its dNTP triphosphohydrolase (dNTPase) activity. Human SAMHD1 interacts with cell cycle regulatory proteins cyclin A2, cyclin-dependent kinase 1 (CDK1), and CDK2. This interaction mediates phosphorylation of SAMHD1 at threonine 592 (T592), which negatively regulates HIV-1 restriction. We previously reported that the interaction is mediated, at least in part, through a cyclin-binding motif (RXL, amino acids [aa] 451 to 453). To understand the role of the RXL motif in regulating SAMHD1 activity, we performed structural and functional analyses of RXL mutants and the effect on HIV-1 restriction. We found that the RXL mutation (R451A and L453A, termed RL/AA) disrupted SAMHD1 tetramer formation and abolished its dNTPase activity in vitro and in cells. Compared to wild-type (WT) SAMHD1, the RL/AA mutant failed to restrict HIV-1 infection and had reduced binding to cyclin A2. WT SAMHD1 and RL/AA mutant proteins were degraded by Vpx from HIV-2 but were not spontaneously ubiquitinated in the absence of Vpx. Analysis of proteasomal and autophagy degradation revealed that WT and RL/AA SAMHD1 protein levels were enhanced only when both pathways of degradation were simultaneously inhibited. Our results demonstrate that the RXL motif of human SAMHD1 is required for its HIV-1 restriction, tetramer formation, dNTPase activity, and efficient phosphorylation at T592. These findings identify a new functional domain of SAMHD1 important for its structural integrity, enzyme activity, phosphorylation, and HIV-1 restriction.IMPORTANCE SAMHD1 is the first mammalian dNTPase identified as a restriction factor that inhibits HIV-1 replication by decreasing the intracellular dNTP pool in nondividing cells, although the critical mechanisms regulating SAMHD1 function remain unclear. We previously reported that mutations of a cyclin-binding RXL motif in human SAMHD1 significantly affect protein expression levels, half-life, nuclear localization, and phosphorylation, suggesting an important role of this motif in modulating SAMHD1 functions in cells. To further understand the significance and mechanisms of the RXL motif in regulating SAMHD1 activity, we performed structural and functional analyses of the RXL motif mutation and its effect on HIV-1 restriction. Our results indicate that the RXL motif is critical for tetramer formation, dNTPase activity, and HIV-1 restriction. These findings help us understand SAMHD1 interactions with other host proteins and the mechanisms regulating SAMHD1 structure and functions in cells.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  HIV-1; SAMHD1; cyclin binding; dNTPase; infection; restriction; structure

Mesh:

Substances:

Year:  2018        PMID: 29321329      PMCID: PMC5827405          DOI: 10.1128/JVI.01787-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  77 in total

1.  SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells.

Authors:  Hanna-Mari Baldauf; Xiaoyu Pan; Elina Erikson; Sarah Schmidt; Waaqo Daddacha; Manja Burggraf; Kristina Schenkova; Ina Ambiel; Guido Wabnitz; Thomas Gramberg; Sylvia Panitz; Egbert Flory; Nathaniel R Landau; Serkan Sertel; Frank Rutsch; Felix Lasitschka; Baek Kim; Renate König; Oliver T Fackler; Oliver T Keppler
Journal:  Nat Med       Date:  2012-11       Impact factor: 53.440

2.  A Highly Active Isoform of Lentivirus Restriction Factor SAMHD1 in Mouse.

Authors:  Nicolin Bloch; Sabine Gläsker; Poojitha Sitaram; Henning Hofmann; Caitlin N Shepard; Megan L Schultz; Baek Kim; Nathaniel R Landau
Journal:  J Biol Chem       Date:  2016-12-05       Impact factor: 5.157

Review 3.  Degradation of oxidized proteins in mammalian cells.

Authors:  T Grune; T Reinheckel; K J Davies
Journal:  FASEB J       Date:  1997-06       Impact factor: 5.191

4.  Methods in mammalian autophagy research.

Authors:  Noboru Mizushima; Tamotsu Yoshimori; Beth Levine
Journal:  Cell       Date:  2010-02-05       Impact factor: 41.582

5.  Downregulation of SAMHD1 expression correlates with promoter DNA methylation in Sézary syndrome patients.

Authors:  Suresh de Silva; Feifei Wang; Timothy S Hake; Pierluigi Porcu; Henry K Wong; Li Wu
Journal:  J Invest Dermatol       Date:  2013-07-24       Impact factor: 8.551

6.  The deoxynucleotide triphosphohydrolase SAMHD1 is a major regulator of DNA precursor pools in mammalian cells.

Authors:  Elisa Franzolin; Giovanna Pontarin; Chiara Rampazzo; Cristina Miazzi; Paola Ferraro; Elisa Palumbo; Peter Reichard; Vera Bianchi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-15       Impact factor: 11.205

7.  A bipartite substrate recognition motif for cyclin-dependent kinases.

Authors:  D Y Takeda; J A Wohlschlegel; A Dutta
Journal:  J Biol Chem       Date:  2000-11-06       Impact factor: 5.157

8.  The retroviral restriction ability of SAMHD1, but not its deoxynucleotide triphosphohydrolase activity, is regulated by phosphorylation.

Authors:  Tommy E White; Alberto Brandariz-Nuñez; Jose Carlos Valle-Casuso; Sarah Amie; Laura Anh Nguyen; Baek Kim; Marina Tuzova; Felipe Diaz-Griffero
Journal:  Cell Host Microbe       Date:  2013-04-17       Impact factor: 21.023

9.  Characterization of human immunodeficiency virus type 1 replication in immature and mature dendritic cells reveals dissociable cis- and trans-infection.

Authors:  Chunsheng Dong; Alicia M Janas; Jian-Hua Wang; Wendy J Olson; Li Wu
Journal:  J Virol       Date:  2007-08-08       Impact factor: 5.103

10.  Tetramerization of SAMHD1 is required for biological activity and inhibition of HIV infection.

Authors:  Junpeng Yan; Sarabpreet Kaur; Maria DeLucia; Caili Hao; Jennifer Mehrens; Chuanping Wang; Marcin Golczak; Krzysztof Palczewski; Angela M Gronenborn; Jinwoo Ahn; Jacek Skowronski
Journal:  J Biol Chem       Date:  2013-02-20       Impact factor: 5.157

View more
  9 in total

1.  HIV-2 Depletes CD4 T Cells through Pyroptosis despite Vpx-Dependent Degradation of SAMHD1.

Authors:  Xiaoyu Luo; Eytan Herzig; Gilad Doitsh; Zachary W Grimmett; Isa Muñoz-Arias; Warner C Greene
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

2.  The C-terminal domain of feline and bovine SAMHD1 proteins has a crucial role in lentiviral restriction.

Authors:  Chu Wang; Kaikai Zhang; Lina Meng; Xin Zhang; Yanan Song; Ying Zhang; Yanxin Gai; Yuepeng Zhang; Bin Yu; Jiaxin Wu; Song Wang; Xianghui Yu
Journal:  J Biol Chem       Date:  2020-02-19       Impact factor: 5.157

Review 3.  SAMHD1 Suppression of Antiviral Immune Responses.

Authors:  Shuliang Chen; Serena Bonifati; Zhihua Qin; Corine St Gelais; Li Wu
Journal:  Trends Microbiol       Date:  2018-10-15       Impact factor: 17.079

4.  The structural basis for cancer drug interactions with the catalytic and allosteric sites of SAMHD1.

Authors:  Kirsten M Knecht; Olga Buzovetsky; Constanze Schneider; Dominique Thomas; Vishok Srikanth; Lars Kaderali; Florentina Tofoleanu; Krystle Reiss; Nerea Ferreirós; Gerd Geisslinger; Victor S Batista; Xiaoyun Ji; Jindrich Cinatl; Oliver T Keppler; Yong Xiong
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-10       Impact factor: 11.205

5.  Interferon γ and α Have Differential Effects on SAMHD1, a Potent Antiviral Protein, in Feline Lymphocytes.

Authors:  Peyman Asadian; Dorothee Bienzle
Journal:  Viruses       Date:  2019-10-09       Impact factor: 5.048

Review 6.  Activating the DNA Damage Response and Suppressing Innate Immunity: Human Papillomaviruses Walk the Line.

Authors:  Claire D James; Dipon Das; Molly L Bristol; Iain M Morgan
Journal:  Pathogens       Date:  2020-06-13

Review 7.  From APOBEC to ZAP: Diverse mechanisms used by cellular restriction factors to inhibit virus infections.

Authors:  Mahesh Chemudupati; Adam D Kenney; Serena Bonifati; Ashley Zani; Temet M McMichael; Li Wu; Jacob S Yount
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2018-10-02       Impact factor: 4.739

8.  Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML.

Authors:  Thomas Oellerich; Constanze Schneider; Dominique Thomas; Kirsten M Knecht; Olga Buzovetsky; Lars Kaderali; Christoph Schliemann; Hanibal Bohnenberger; Linus Angenendt; Wolfgang Hartmann; Eva Wardelmann; Tamara Rothenburger; Sebastian Mohr; Sebastian Scheich; Federico Comoglio; Anne Wilke; Philipp Ströbel; Hubert Serve; Martin Michaelis; Nerea Ferreirós; Gerd Geisslinger; Yong Xiong; Oliver T Keppler; Jindrich Cinatl
Journal:  Nat Commun       Date:  2019-08-02       Impact factor: 14.919

Review 9.  SAMHD1 Functions and Human Diseases.

Authors:  Si'Ana A Coggins; Bijan Mahboubi; Raymond F Schinazi; Baek Kim
Journal:  Viruses       Date:  2020-03-31       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.